Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Lifecore Biomedical, Inc. (LFCR) had Normalized Income after Taxes of $-9.99M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$31.11M |
|
$-10.91M |
|
$23.32M |
|
$7.79M |
|
$34.18M |
|
$-3.07M |
|
$-6.59M |
|
$-9.66M |
|
$-9.66M |
|
$-9.99M |
|
$-9.99M |
|
$-9.99M |
|
|
Normalized Income after Taxes |
$-9.99M |
$-3.07M |
|
$-3.07M |
|
37.40M |
|
37.40M |
|
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$83.93M |
|
$128.57M |
|
$151.28M |
|
$235.20M |
|
$29.96M |
|
$160.50M |
|
$168.46M |
|
$198.42M |
|
$-10.54M |
|
$18.70M |
|
$36.79M |
|
37.47M |
|
| Cash Flow Statement Financials | |
$1.76M |
|
$-1.74M |
|
$-1.39M |
|
$20.22M |
|
$18.86M |
|
$-1.36M |
|
$2.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|